Proteome Sciences has established a comprehensive intellectual property portfolio covering markers in CNS disorders (Alzheimer’s, stroke, traumatic brain injury, TSE’s & pain), Cancer (lung, breast, esophageal, colorectal cancers & neuroblastoma) and organ transplant rejection(renal, cardiac).
All biomarker portfolios are available for licensing to companies wishing to develop targeted assays for research and/or clinical use.
A list of selected applications from tissue and body fluids available upon request.
Corporate and Registered Office
Proteome Sciences plc
Tel: +44 (0)20 7043 2116
Fax: +44 (0)20 3637 7516